These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6268245)

  • 41. Brain receptor binding characteristics and pharmacokinetics of JTP-2942, a novel thyrotropin-releasing hormone (TRH) analogue.
    Urayama A; Yamada S; Deguchi Y; Kimura R; Maeda Y; Kobayashi T
    Life Sci; 1999; 65(22):2407-15. PubMed ID: 10597895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between receptor-binding affinities and TSH-releasing activities of novel TRH analogs in the rat.
    Shikata M; Tsuda M; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1982 Oct; 32(5):883-91. PubMed ID: 6816971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Limbic, hypothalamic, cortical and spinal regions are enriched in receptors for thyrotropin-releasing hormone: evidence from [3H]ultrofilm autoradiography and correlation with central effects of the tripeptide in rat brain.
    Sharif NA; Burt DR
    Neurosci Lett; 1985 Oct; 60(3):337-42. PubMed ID: 2999650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel TRH analog, Glp-Asn-Pro-D-Tyr-D-TrpNH2, binds to [3H][3-Me-His2]TRH-labelled sites in rat hippocampus and cortex but not pituitary or heterologous cells expressing TRHR1 or TRHR2.
    Hogan N; O'Boyle KM; Hinkle PM; Kelly JA
    Neurosci Lett; 2008 Jan; 431(1):26-30. PubMed ID: 18069127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two novel thioamide analogues of TRH with selective activity on CNS.
    Alexandrová M; Strbák V; Kruszynski M; Zboinska J; Kupryszewski G
    Gen Physiol Biophys; 1991 Jun; 10(3):287-97. PubMed ID: 1655558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thyrotropin-releasing hormone effects on phosphatidylinositol metabolism and binding in rat pituitary and retina.
    Naseem SM
    Biochem Int; 1989 Jan; 18(1):203-10. PubMed ID: 2541721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thyrotropin releasing hormone (TRH) binding sites in the adult human brain: localization and characterization.
    Parker CR; Capdevila A
    Peptides; 1984; 5(4):701-6. PubMed ID: 6093073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of thyrotropin releasing hormone (TRH) receptors in rat brain.
    Ogawa N; Yamawaki Y; Kuroda H; Nukina I; Ota Z; Fujino M; Yanaihara N
    Peptides; 1982; 3(4):669-77. PubMed ID: 6291012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroidal inhibition of growth hormone secretion in fowl: tri-iodothyronine-induced down-regulation of thyrotrophin-releasing hormone-binding sites on pituitary membranes.
    Harvey S; Baidwan JS
    J Mol Endocrinol; 1990 Apr; 4(2):127-34. PubMed ID: 2160826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance of extracellular domains for ligand binding in the thyrotropin-releasing hormone receptor.
    Han B; Tashjian AH
    Mol Endocrinol; 1995 Dec; 9(12):1708-19. PubMed ID: 8614407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Bhargava HN; Gulati A
    Pharmacology; 1988; 37(6):349-55. PubMed ID: 2854272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TRH analogue with C-terminal thioamide group. Synthesis, receptor binding, TSH-releasing activity and alpha-MSH-releasing activity.
    Kruszyński M; Kupryszewski G; Ragnarsson U; Alexandrova M; Strbak V; Tonon MC; Vaudry H
    Experientia; 1985 Dec; 41(12):1576-7. PubMed ID: 3000815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRH analogue with C-terminal thioamide group: rapid degradation by plasma and its biological effects.
    Angyal R; Strbák V; Alexandrová M; Kruszyński M
    Endocrinol Exp; 1985 Dec; 19(4):213-9. PubMed ID: 3002750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solubilization and characterization of pituitary thyrotropin-releasing hormone receptors.
    Phillips WJ; Hinkle PM
    Mol Pharmacol; 1989 Apr; 35(4):533-40. PubMed ID: 2539560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells.
    Atley LM; Lefroy N; Wark JD
    J Endocrinol; 1995 Dec; 147(3):397-404. PubMed ID: 8543909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological and biochemical comparison of thyrotropin releasing hormone (TRH) and di-methyl proline-TRH on pituitary GH3 cells.
    McDermott AM; Wilkin GP; Dickinson SL
    Br J Pharmacol; 1990 Nov; 101(3):615-20. PubMed ID: 1963801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
    Bhargava HN; Das S
    Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of thyrotropin-releasing hormone binding sites: autoradiographic study in infant and adult human hippocampal formation.
    Eymin C; Champier J; Duvernoy HM; Martin D; Kopp N; Jordan D
    Brain Res; 1993 Mar; 605(1):139-46. PubMed ID: 8467383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of GH4C1 cell variants to demonstrate a non-spare receptor model for thyrotropin-releasing hormone action.
    Ramsdell JS; Tashjian AH
    Mol Cell Endocrinol; 1985 Dec; 43(2-3):173-80. PubMed ID: 3000850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence that the thyrotropin-releasing hormone receptor and its ligand are recycled dissociated from each other.
    Petrou CP; Tashjian AH
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):107-13. PubMed ID: 7864795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.